yttrium radioisotopes has been researched along with Breast Neoplasms in 93 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 18 (19.35) | 18.7374 |
1990's | 16 (17.20) | 18.2507 |
2000's | 23 (24.73) | 29.6817 |
2010's | 27 (29.03) | 24.3611 |
2020's | 9 (9.68) | 2.80 |
Authors | Studies |
---|---|
Aarts, BM; Beets-Tan, RGH; Deroose, CMALO; Dresen, RC; Klompenhouwer, EG; Maleux, G; Neven, P; Punie, K; Wildiers, H | 1 |
Bercu, ZL; Davisson, NA; Ermentrout, RM; Friend, SC; Kokabi, N; Majdalany, BS; Newsome, J; Paplomata, E | 1 |
Barron, B; Bercu, Z; Brandon, D; Cheng, B; Davisson, N; Galt, J; Kokabi, N; Schuster, DM; Sethi, I | 1 |
Debus, J; Fuxius, S; Giesel, FL; Haberkorn, U; Kratochwil, C; Lindner, T; Rathke, H | 1 |
Padia, SA | 1 |
Abdalla, E; Bercu, Z; Friend, S; Gogineni, K; Kalinsky, K; Kokabi, N; Levy, J; Meisel, J; Natarajan, N; Sethi, I; Switchenko, J; Szabo, S; Thirunavu, M; Weakland, L; Wu, R | 1 |
Iezzi, R; Indovina, L; Moretti, R; Perrone, E; Zagaria, L | 1 |
Boas, FE; Deipolyi, AR; England, RW; Kunin, HS; Ridouani, F; Riedl, CC; Sofocleous, CT; Yarmohammadi, H | 2 |
Boas, FE; Deipolyi, AR; Doustaly, R; England, RW; Hsu, M; Moskowitz, CS; Ridouani, F; Sofocleous, CT; Soliman, MM; Yarmohammadi, H | 1 |
Lam, MG; Nijsen, JF; Prince, JF; Rosenbaum, CE; Seinstra, BA; Smits, ML; van den Bosch, MA; van den Hoven, AF; Zonnenberg, BA | 1 |
Bester, L; Kapoor, J; Meteling, B; Morris, DL; Saxena, A | 1 |
Gates, VL; Gordon, AC; Gradishar, WJ; Kaklamani, VG; Lewandowski, RJ; Ryu, RK; Salem, R; Sato, KT; Thuluvath, AJ | 1 |
Bartenstein, P; Fendler, WP; Goritschan, A; Hacker, M; Haug, AR; Ilhan, H; Jakobs, TF; Paprottka, P | 1 |
Bagni, O; Cianni, R; Filippi, L; Pelle, G; Schillaci, O | 1 |
Bartenstein, P; Fendler, WP; Haug, AR; Jakobs, TF; Lechner, H; Lehner, S; Michl, M; Paprottka, KJ; Paprottka, PM; Todica, A | 1 |
Berliner, L; Golubnitschaja, O; Schild, HH; Stricker, H; Trog, D; Yeghiazaryan, K | 1 |
Ahmadzadehfar, H; Block, W; Kukuk, GM; Meyer, C; Mürtz, P; Pieper, CC; Schild, HH; Sprinkart, AM; Willinek, WA | 1 |
Ahmadzadehfar, H; Block, W; Meyer, C; Nadal, J; Pieper, CC; Schild, HH; Wilhelm, KE; Willinek, WA | 1 |
Gordon, AC; Lewandowski, RJ; Salem, R | 1 |
Manych, M | 1 |
Apuri, S; Kis, B; Loftus, L; Nanjappa, S; Pla-Fernandez, CA | 1 |
Ciuffreda, L; Cuttitta, A; Murgo, RM; Scaramuzzi, G | 1 |
Brown, DB; Garcia-Ramirez, J; Goddu, SM; Myerson, RJ; Pilgram, TK; Stuart, JE; Tan, B | 1 |
Helmberger, TK; Hoffmann, RT; Jakobs, TF; Kubisch, CH; Reiser, MF; Stemmler, HJ; Tatsch, K; Trumm, C | 1 |
Carbone, G; Cremonesi, M; De Cicco, C; De Santis, R; Di Dia, A; Ferrari, A; Ferrari, ME; Galimberti, V; Leonardi, MC; Luini, A; Orecchia, R; Pacifici, M; Paganelli, G; Pagani, G; Veronesi, U; Zurrida, S | 1 |
Al-Nahhas, A; Gordon, F; Habib, N; Hodolic, M; Karunanithy, N; Tait, NP; Wasan, HS | 1 |
Colcher, D; Raubitschek, A; Shively, JE; Somlo, G; Williams, LE; Wong, JY; Wu, AM; Yamauchi, D; Yazaki, P | 1 |
Coldwell, D; Kennedy, A; Salem, R; Sangro, B; Wasan, H | 1 |
Moadel, RM | 1 |
Hoffmann, RT; Jakobs, TF; Paprottka, P; Reiser, MF; Trumm, CG | 1 |
Hoffmann, RT; Jakobs, TF; Paprottka, PM; Reiser, MF; Schmidt, GP; Trumm, CG | 1 |
Antoch, G; Bockisch, A; Ertle, J; Gerken, G; Hamami, M; Heusner, TA; Lauenstein, TC; Schlaak, JF | 1 |
Bartenstein, P; Hacker, M; Haug, AR; Heinemann, V; Laubender, RP; Michl, M; Tiega Donfack, BP; Trumm, C; Uebleis, C; Zech, CJ | 1 |
Chinol, M; Garaboldi, L; González, IH; Montaña, RL; Ramirez, AA | 1 |
Bagni, O; Cianni, R; Cortesi, E; Filippi, L; Notarianni, E; Pelle, G; Rabuffi, P; Saltarelli, A | 1 |
Botta, F; Calabrese, M; Cremonesi, M; De Cicco, C; Di Dia, A; Ferrari, ME; Orecchia, R; Paganelli, G; Pedicini, P; Pedroli, G; Sarnelli, A | 1 |
Bakos, G; Hohdorf, K; Kretzschmar, A; Plötner, A; Scheibe, J; Wallstabe, I; Wegner, D | 1 |
Blend, MJ; Brechbiel, MW; Stastny, JJ; Swanson, SM | 1 |
EDELSTYN, GA; GLEADHILL, CA; LYONS, AR; RODGERS, HW; TAYLOR, AR; WELBOURN, RB | 1 |
BLAIR, DW; FORREST, AP; VALENTINE, JM | 1 |
IRONSIDE, WM; MOSELEY, RD | 1 |
FRASER, R; JOPLIN, GF; LAWS, JW; MORRISON, R; STEINER, RE | 1 |
EVANS, JP; FENGE, W; HARPER, PV; KELLY, WA | 1 |
RAMSAY, GS | 1 |
HAYEM, M; JURET, P | 1 |
FORREST, AP | 1 |
FESANI, F; GOFFRINI, P; PERACCHIA, A | 1 |
BERINGER, A; BURIAN, K; ELLEGAST, H; FANTA, H; FRISCHAUF, H | 1 |
Blumenthal, RD | 1 |
Jones, B; Nutting, C; Rubin, D | 1 |
Adams, GP; Brechbiel, MW; Dadachova, E; Horak, EM; Klein-Szanto, AJ; Marks, JD; Shaller, CC; Simmons, HH; Tesfaye, A; Weiner, LM | 1 |
Reddy, JC; Reyno, LM; Vogel, CL | 1 |
DeNardo, GL; DeNardo, SJ; Kroger, LA; O'Donnell, RT; Richman, CM; Shen, S; Siantar, CH; Yuan, A | 1 |
Chew, HK; DeNardo, GL; Denardo, SJ; Goldstein, DS; Kukis, DL; Lamborn, KR; Lara, PN; Meares, CF; Natarajan, A; O'Donnell, RT; Richman, CM; Shen, S; Tuscano, JM; Wun, T; Yuan, A | 1 |
Brechbiel, MW; Kelly, MP; Lee, FT; Scott, AM; Smyth, FE | 1 |
Brock, H; Günther, RW; Haage, P | 1 |
DeNardo, GL; DeNardo, SJ; Lehmann, J; O'Donnell, RT; Richman, CM; Shen, S; Yuan, A | 1 |
Carminati, P; Cremonesi, M; De Cicco, C; Ferrari, M; Fiorenza, M; Galimberti, V; Luini, A; Orecchia, R; Paganelli, G; Veronesi, P; Veronesi, U; Zanna, C | 1 |
Atassi, B; Bangash, AK; Gates, VL; Gradishar, W; Kaklamani, V; Lewandowski, RJ; Mandal, R; Newman, S; Omary, RA; Rhee, TK; Ryu, RK; Salem, R; Sato, KT; Yu, M | 1 |
Coldwell, DM; Kennedy, AS; Nutting, CW | 1 |
Carminati, P; Chinol, M; Cremonesi, M; De Cicco, C; De Santis, R; Ferrari, M; Fiorenza, M; Galimberti, V; Luini, A; Paganelli, G; Papi, S; Ravasi, L; Sivolapenko, G; Travaini, LL; Veronesi, U; Zanna, C | 1 |
Helmberger, TK; Hoffmann, RT; Jakobs, TF; Reiser, MF; Tatsch, K; Trumm, C | 1 |
Abdel-Misih, R; Dignazio, M; Garcia, M; Khatri, J; Neff, R; Petrelli, N; Wilson, P | 1 |
Fischer, T; Helmberger, TK; Hoffmann, RT; Jakobs, TF; La Fougere, C; Murthy, R; Reiser, MF; Stemmler, HJ; Tatsch, K | 1 |
Becker, M; Brod, KH; Dähnert, W; Grimm, W; Kutzner, J; Schreyer, T | 1 |
Hammer, J | 1 |
DeNardo, SJ; Kukis, DL; Li, M; Meares, CF; Miers, L; Salako, Q; Zhong, GR | 1 |
Chi, SG; DeNardo, GL; DeNardo, SJ; deVere White, RW; Gumerlock, PH; Lamborn, KR; Mack, PC; Miers, LA; Shen, S; Winthrop, MD | 1 |
Ceriani, RL; Couto, JR; Peterson, JA; Taylor, MR | 1 |
Butchko, G; Dufton, C; Glenn, SD; Johnson, T; Kasliwal, R; Lear, J; Matthes, S; Schrier, DM; Stemmer, SM; Taffs, S | 1 |
Ceriani, R; DeNardo, SJ; Furmanski, P; Glenn, SD; Kramer, EL; Kroger, L; Liebes, L; Noz, ME | 1 |
Feinendegen, LE; Herzog, H; Lueders, C; Qaim, SM; Rösch, F; Stöcklin, G | 1 |
Appelbaum, FR; Bernstein, ID; Eary, J; Haines, AM; Hamann, P; Hinman, L; Howell-Clark, J; King, DJ; Matthews, D; Press, OW; Shan, D; Shochat, D | 1 |
DeNardo, DG; DeNardo, GL; DeNardo, SJ; Kroger, LA; Kukis, DL; Lamborn, KR; Meares, CF; Miers, LA; O'Donnell, RT | 1 |
Ceriani, RL; DeNardo, GL; DeNardo, SJ; Glenn, SD; Kramer, EL; Noz, M; O'Donnell, RT; Richman, CM; Salako, QA; Shen, S | 1 |
DeNardo, GL; DeNardo, SJ; Gumerlock, PH; Kroger, LA; Kukis, DL; Lamborn, KR; Meares, CF; Miers, LA; Salako, Q; Shen, S; Winthrop, MD | 1 |
Blank, EW; Ceriani, RL; Furmanski, P; Kramer, EL; Liebes, L; Melamed, J; Noz, ME; Peterson, JA; Wasserheit, C; Zabalegui, A | 1 |
Angelberger, P; Bischof, C; Gludovacz, D; Hamilton, G; Kaserer, K; Kofler, A; Leimer, M; Pangerl, T; Peck-Radosavljevic, M; Schlangbauer-Wadl, H; Smith-Jones, PM; Traub, T; Virgolini, I | 1 |
Doroshow, JH; Forman, S; Liu, A; Odom-Maryon, T; Raubitschek, AA; Shively, JE; Somlo, G; Wilczynski, S; Williams, LE; Wong, JY; Wu, AM; Yamauchi, D; Yazaki, P | 1 |
Boniface, GR; DeNardo, GL; DeNardo, SJ; Goldstein, DS; Griffith, IJ; Kroger, LA; Kukis, DL; O'Donnell, RT; Richman, CM; Shen, S; Yuan, A | 1 |
Bakker, W; Chen, T; Jamar, F; Krenning, E; Kvols, L; Liu, J; Pauwels, S; Schran, H; Smith, MC; Valkema, R; Yeh, CM | 1 |
Brechbiel, MW; Clarke, K; Lee, FT; Old, LJ; Scott, AM; Smyth, FE | 1 |
DeNardo, SJ; Richman, CM | 1 |
Blank, E; Ceriani, R; Furmanski, P; Hochster, H; Kramer, E; Liebes, L; Ng, B; Wasserheit, C | 1 |
Wense, G | 1 |
Forrest, AP; McFadyen, I; Roberts, MM; Stewart, HJ; Sumerling, M | 1 |
Buchan, R; Forrest, AP; Golder, MP; Griffiths, K; Groom, GV; McFadyen, IJ; Raab, G | 1 |
Cant, E; Forrest, AP; Griffiths, K; Groom, GV; McFadyen, IJ; Raab, G | 1 |
Lee, KJ | 1 |
Courtenay-Luck, NS; Epenetos, AA; Gooden, CS; Kosmas, C; McCall, MJ; Meares, CF; Snook, D | 1 |
Adamas, GP; DeNardo, GL; DeNardo, SJ; Deshpande, SV; McCall, MK; Meares, CF; Moi, MK | 1 |
Bundred, NJ; Dale, BA; Eremin, O; Forrest, AP; Stewart, HJ | 1 |
8 review(s) available for yttrium radioisotopes and Breast Neoplasms
Article | Year |
---|---|
Y90 Clinical Data Update: Cholangiocarcinoma, Neuroendocrine Tumor, Melanoma, and Breast Cancer Metastatic Disease.
Topics: Breast Neoplasms; Cholangiocarcinoma; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Melanoma; Microspheres; Neuroendocrine Tumors; Radiography, Interventional; Yttrium Radioisotopes | 2019 |
Intra-arterial radioembolization of breast cancer liver metastases: a structured review.
Topics: Breast Neoplasms; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Microspheres; Radiopharmaceuticals; Salvage Therapy; Stomach Ulcer; Survival Analysis; Tumor Burden; Yttrium Radioisotopes | 2013 |
Radioembolization in the treatment of unresectable liver tumors: experience across a range of primary cancers.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Breast Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colorectal Neoplasms; Embolization, Therapeutic; Glass; Hepatectomy; Humans; Liver Neoplasms; Lung Neoplasms; Melanoma; Microspheres; Resins, Synthetic; Treatment Outcome; Uveal Neoplasms; Yttrium Radioisotopes | 2012 |
Breast cancer imaging devices.
Topics: Animals; Breast Neoplasms; Diagnostic Imaging; Gamma Cameras; Humans; Organ Specificity; Radiography; Radionuclide Imaging; Sentinel Lymph Node Biopsy; Yttrium Radioisotopes | 2011 |
Arterial therapies of non-colorectal cancer metastases to the liver (from chemoembolization to radioembolization).
Topics: Antineoplastic Agents; Breast Neoplasms; Chemoembolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Melanoma; Microspheres; Neuroendocrine Tumors; Pancreatic Neoplasms; Yttrium Radioisotopes | 2011 |
[Developments and perspectives in radioablative techniques].
Topics: Antineoplastic Agents; Brachytherapy; Breast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Neuroendocrine; Chemoembolization, Therapeutic; Colorectal Neoplasms; Combined Modality Therapy; Female; Humans; Liver Neoplasms; Male; Microspheres; Neoplasms; Radiation-Sensitizing Agents; Radiography; Radiology, Interventional; Randomized Controlled Trials as Topic; Yttrium Radioisotopes | 2007 |
OctreoTher: ongoing early clinical development of a somatostatin-receptor-targeted radionuclide antineoplastic therapy.
Topics: Animals; Breast Neoplasms; Carcinoma, Small Cell; Dose-Response Relationship, Radiation; Female; Humans; Indium Radioisotopes; Lung Neoplasms; Male; Mice; Mice, Nude; Neoplasms; Neuroendocrine Tumors; Octreotide; Radiopharmaceuticals; Receptors, Somatostatin; Somatostatin; Yttrium Radioisotopes | 2000 |
Systemic radiotherapy in metastatic breast cancer using 90Y-linked monoclonal MUC-1 antibodies.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Neoplasm Metastasis; Radioimmunotherapy; Yttrium Radioisotopes | 2001 |
14 trial(s) available for yttrium radioisotopes and Breast Neoplasms
Article | Year |
---|---|
Study Protocol: Efficacy and Safety of Radioembolization (REM) as an Early Modality (EM) Therapy for Metastatic Breast Cancer (BR) to the Liver with Y90 (REMEMBR Y90).
Topics: Abdomen; Adolescent; Adult; Breast Neoplasms; Clinical Trials, Phase II as Topic; Female; Humans; Liver Neoplasms; Melanoma, Cutaneous Malignant; Multicenter Studies as Topic; Prospective Studies; Quality of Life; Randomized Controlled Trials as Topic; Treatment Outcome; Yttrium Radioisotopes | 2022 |
Intraoperative avidination for radionuclide treatment as a radiotherapy boost in breast cancer: results of a phase II study with (90)Y-labeled biotin.
Topics: Adult; Aged; Avidin; Biotin; Breast Neoplasms; Drug Delivery Systems; Female; Humans; Intraoperative Care; Middle Aged; Radioimmunotherapy; Radiopharmaceuticals; Radiotherapy, Adjuvant; Treatment Outcome; Yttrium Radioisotopes | 2010 |
Technology evaluation: cT84.66, City of Hope.
Topics: Breast Neoplasms; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; Humans; Immunoglobulin G; Male; Radioimmunotherapy; Structure-Activity Relationship; Yttrium Radioisotopes | 2004 |
High-dose radioimmunotherapy combined with fixed, low-dose paclitaxel in metastatic prostate and breast cancer by using a MUC-1 monoclonal antibody, m170, linked to indium-111/yttrium-90 via a cathepsin cleavable linker with cyclosporine to prevent human
Topics: Adult; Aged; Aged, 80 and over; Animals; Antibodies, Monoclonal; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Breast Neoplasms; Cathepsins; Combined Modality Therapy; Cyclosporine; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Female; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Male; Mice; Middle Aged; Neutropenia; Paclitaxel; Prostatic Neoplasms; Radioimmunotherapy; Soft Tissue Neoplasms; Treatment Outcome; Yttrium Radioisotopes | 2005 |
90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survival.
Topics: Brachytherapy; Breast Neoplasms; Female; Humans; Liver Neoplasms; Microspheres; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2007 |
Intraoperative avidination for radionuclide therapy: a prospective new development to accelerate radiotherapy in breast cancer.
Topics: Adolescent; Adult; Aged; Avidin; Biotin; Brachytherapy; Breast Neoplasms; Combined Modality Therapy; Female; Humans; Indium Radioisotopes; Injections, Intralesional; Injections, Intravenous; Intraoperative Period; Mastectomy, Segmental; Middle Aged; Organometallic Compounds; Pilot Projects; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy, Adjuvant; Sentinel Lymph Node Biopsy; Tissue Distribution; Yttrium Radioisotopes | 2007 |
Selection of tumor-specific epitopes on target antigens for radioimmunotherapy of breast cancer.
Topics: 3T3 Cells; Amino Acid Sequence; Animals; Antibodies, Monoclonal; Antigens, Neoplasm; Breast Neoplasms; Cell Adhesion; Epitope Mapping; Female; Humans; Mice; Mice, Nude; Molecular Sequence Data; Neoplasm Transplantation; Radioimmunotherapy; Yttrium Radioisotopes | 1995 |
High-dose 90Y Mx-diethylenetriaminepentaacetic acid (DTPA)-BrE-3 and autologous hematopoietic stem cell support (AHSCS) for the treatment of advanced breast cancer: a phase I trial.
Topics: Adult; Aged; Animals; Antibodies, Monoclonal; Breast Neoplasms; Combined Modality Therapy; Female; Hematopoietic Stem Cell Transplantation; Humans; Mice; Middle Aged; Pentetic Acid; Radioimmunotherapy; Yttrium Radioisotopes | 1995 |
Radioimmunolocalization of breast cancer using BrE-3 monoclonal antibody.
Topics: Animals; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Antibody Specificity; Biomarkers, Tumor; Breast Neoplasms; Carcinoembryonic Antigen; Female; Humans; Immunoconjugates; Indium Radioisotopes; Membrane Glycoproteins; Mice; Middle Aged; Mucin-1; Mucins; Pentetic Acid; Radioimmunodetection; Yttrium Radioisotopes | 1994 |
Radioimmunotherapy for breast cancer using indium-111/yttrium-90 BrE-3: results of a phase I clinical trial.
Topics: Breast Neoplasms; Chelating Agents; Female; Humans; Indium Radioisotopes; Middle Aged; Pentetic Acid; Radioimmunotherapy; Radiotherapy Dosage; Yttrium Radioisotopes | 1997 |
Initial clinical experience evaluating Yttrium-90-chimeric T84.66 anticarcinoembryonic antigen antibody and autologous hematopoietic stem cell support in patients with carcinoembryonic antigen-producing metastatic breast cancer.
Topics: Animals; Breast Neoplasms; Carcinoembryonic Antigen; Combined Modality Therapy; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulin G; Mice; Pentetic Acid; Radioimmunoassay; Recombinant Fusion Proteins; Transplantation, Autologous; Yttrium Radioisotopes | 1999 |
Yttrium implant for advanced breast cancer.
Topics: Adrenalectomy; Breast Neoplasms; Castration; Clinical Trials as Topic; Female; Humans; Hypophysectomy; Methods; Pituitary Gland; Remission, Spontaneous; Yttrium Radioisotopes | 1977 |
The effect of chemotherapy on pituitary function in patients with advanced breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Follicle Stimulating Hormone; Growth Hormone; Humans; Luteinizing Hormone; Pituitary Function Tests; Prolactin; Yttrium Radioisotopes | 1979 |
Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy.
Topics: Aged; Antibodies; Antibodies, Monoclonal; Antibody Formation; Breast; Breast Neoplasms; Chelating Agents; Drug Evaluation; Female; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Male; Middle Aged; Neoplasm Staging; Neoplasms; Ovarian Neoplasms; Radioimmunotherapy; Radionuclide Imaging; Stomach Neoplasms; Testicular Neoplasms; Yttrium Radioisotopes | 1992 |
71 other study(ies) available for yttrium radioisotopes and Breast Neoplasms
Article | Year |
---|---|
Sequential intra-arterial infusion of 90Y-resin microspheres and mitomycin C in chemo refractory liver metastatic breast cancer patients: a single centre pilot study.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Body Surface Area; Breast Neoplasms; Combined Modality Therapy; Disease Progression; Drug Resistance, Neoplasm; Embolization, Therapeutic; Feasibility Studies; Female; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Microspheres; Middle Aged; Mitomycin; Pilot Projects; Prospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2020 |
Predictors of Survival after Yttrium-90 Radioembolization of Chemotherapy-Refractory Hepatic Metastases from Breast Cancer.
Topics: Adult; Aged; Breast Neoplasms; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2020 |
Yttrium-90 dosimetry and implications on tumour response and survival after radioembolisation of chemo-refractory hepatic metastases from breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Radiometry; Survival Analysis; Yttrium Radioisotopes | 2021 |
Two Tumors, One Target: Preliminary Experience With 90Y-FAPI Therapy in a Patient With Metastasized Breast and Colorectal Cancer.
Topics: Bone Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Female; Humans; Positron Emission Tomography Computed Tomography; Yttrium Radioisotopes | 2021 |
Synchronous Treatment of Breast Cancer Hepatic Metastases by Transarterial Radioembolization and Radiofrequency Thermoablation: A Case Report.
Topics: Breast Neoplasms; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Microspheres; Middle Aged; Retrospective Studies; Technetium Tc 99m Aggregated Albumin; Yttrium Radioisotopes | 2023 |
PET/CT Imaging Characteristics After Radioembolization of Hepatic Metastasis from Breast Cancer.
Topics: Brachytherapy; Breast Neoplasms; Female; Humans; Liver; Liver Neoplasms; Middle Aged; Positron Emission Tomography Computed Tomography; Retrospective Studies; Yttrium Radioisotopes | 2020 |
Reply to: "Regarding 'PET/CT Imaging Characteristics After Radioembolization of Hepatic Metastasis from Breast Cancer'".
Topics: Brachytherapy; Breast Neoplasms; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Yttrium Radioisotopes | 2020 |
Relationship of radiation dose to efficacy of radioembolization of liver metastasis from breast cancer.
Topics: Breast Neoplasms; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Radiation Dosage; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2021 |
Yttrium-90 radioembolization for unresectable, chemoresistant breast cancer liver metastases: a large single-center experience of 40 patients.
Topics: Adult; Aged; Brachytherapy; Breast Neoplasms; Drug Resistance, Neoplasm; Embolization, Therapeutic; Female; Follow-Up Studies; Humans; Liver Neoplasms; Middle Aged; Neoplasm Staging; Prognosis; Prospective Studies; Retrospective Studies; Survival Rate; Yttrium Radioisotopes | 2014 |
Yttrium-90 radioembolization stops progression of targeted breast cancer liver metastases after failed chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease Progression; Embolization, Therapeutic; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Treatment Failure; Yttrium Radioisotopes | 2014 |
Systematic evaluation of tumoral 99mTc-MAA uptake using SPECT and SPECT/CT in 502 patients before 90Y radioembolization.
Topics: Adult; Aged; Aged, 80 and over; Albumins; Angiography, Digital Subtraction; Breast Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Cohort Studies; Colorectal Neoplasms; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Retrospective Studies; Technetium Tc 99m Aggregated Albumin; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Urologic Neoplasms; Yttrium Radioisotopes | 2015 |
Total Lesion Glycolysis and Sequential (90)Y-Selective Internal Radiation Therapy in Breast Cancer Liver Metastases: Preliminary Results.
Topics: Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glycolysis; Humans; Liver Neoplasms; Middle Aged; Positron-Emission Tomography; Survival Rate; Tomography, X-Ray Computed; Tumor Burden; Yttrium Radioisotopes | 2015 |
Safety, Efficacy, and Prognostic Factors After Radioembolization of Hepatic Metastases from Breast Cancer: A Large Single-Center Experience in 81 Patients.
Topics: Angiogenesis Inhibitors; Breast Neoplasms; Embolization, Therapeutic; Endpoint Determination; Female; Fluorodeoxyglucose F18; Humans; Liver Function Tests; Liver Neoplasms; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Treatment Outcome; Tumor Burden; Yttrium Radioisotopes | 2016 |
Patients with hepatic breast cancer metastases demonstrate highly specific profiles of matrix metalloproteinases MMP-2 and MMP-9 after SIRT treatment as compared to other primary and secondary liver tumours.
Topics: Adult; Aged; Brachytherapy; Breast Neoplasms; Chemoembolization, Therapeutic; Female; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Middle Aged; Treatment Outcome; Yttrium Radioisotopes | 2016 |
Intravoxel Incoherent Motion Diffusion-Weighted MR Imaging for Prediction of Early Arterial Blood Flow Stasis in Radioembolization of Breast Cancer Liver Metastases.
Topics: Adult; Aged; Breast Neoplasms; Databases, Factual; Diffusion Magnetic Resonance Imaging; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Middle Aged; Perfusion Imaging; Pilot Projects; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2016 |
Yttrium-90 Radioembolization of Advanced, Unresectable Breast Cancer Liver Metastases-A Single-Center Experience.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Disease Progression; Embolization, Therapeutic; Female; Germany; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Middle Aged; Multivariate Analysis; Palliative Care; Proportional Hazards Models; Radiopharmaceuticals; Risk Factors; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2016 |
Yttrium-90 Radioembolization for Breast Cancer Liver Metastases.
Topics: Breast Neoplasms; Disease Progression; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Palliative Care; Radiopharmaceuticals; Risk Factors; Time Factors; Treatment Outcome; Yttrium Radioisotopes | 2016 |
Topics: Age Distribution; Breast Neoplasms; Comorbidity; Embolization, Therapeutic; Female; Germany; Humans; Incidence; Liver Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Radiotherapy; Sex Distribution; Treatment Outcome; Yttrium Radioisotopes | 2017 |
Liver-Directed Embolization for the Long-Term Control of Hypercalcemia of Malignancy in Metastatic Breast Cancer.
Topics: Aged; Breast Neoplasms; Embolization, Therapeutic; Female; Humans; Hypercalcemia; Liver Neoplasms; Parathyroid Hormone-Related Protein; Prognosis; Radiopharmaceuticals; Yttrium Radioisotopes | 2017 |
[Neuroendocrine carcinoma of the breast. Our experience and a proposal of a therapeutic algorithm for a rare tumor].
Topics: Aged; Aged, 80 and over; Algorithms; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Biopsy; Breast Neoplasms; Carcinoma, Neuroendocrine; Female; Humans; Mastectomy; Middle Aged; Neoplasm Staging; Octreotide; Radionuclide Imaging; Receptors, Somatostatin; Retrospective Studies; Somatostatin; Treatment Outcome; Yttrium Radioisotopes | 2008 |
Salvage radioembolization of liver-dominant metastases with a resin-based microsphere: initial outcomes.
Topics: Acrylic Resins; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Colonic Neoplasms; Drug Carriers; Female; Humans; Liver Neoplasms; Male; Middle Aged; Pilot Projects; Radiography; Radiopharmaceuticals; Retrospective Studies; Salvage Therapy; Treatment Outcome; Yttrium Radioisotopes | 2008 |
Radiofrequency ablation after selective internal radiation therapy with Yttrium90 microspheres in metastatic liver disease-Is it feasible?
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Neuroendocrine; Catheter Ablation; Colorectal Neoplasms; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Retrospective Studies; Yttrium Radioisotopes | 2010 |
Embolization of hepatic arterial branches to simplify hepatic blood flow before yttrium 90 radioembolization: a useful technique in the presence of challenging anatomy.
Topics: Adult; Aged; Breast Neoplasms; Cholangiocarcinoma; Colorectal Neoplasms; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Hepatic Artery; Humans; Liver Circulation; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome; Yttrium Radioisotopes | 2011 |
A pretherapy biodistribution and dosimetry study of indium-111-radiolabeled trastuzumab in patients with human epidermal growth factor receptor 2-overexpressing breast cancer.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Immunoenzyme Techniques; Indium Radioisotopes; Middle Aged; Prognosis; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Receptor, ErbB-2; Tissue Distribution; Trastuzumab; Yttrium Radioisotopes | 2010 |
Changes in normal liver and spleen volume after radioembolization with (90)Y-resin microspheres in metastatic breast cancer patients: findings and clinical significance.
Topics: Adult; Aged; Breast Neoplasms; Breast Neoplasms, Male; Female; Humans; Liver; Liver Neoplasms; Male; Microspheres; Middle Aged; Organ Size; Radiopharmaceuticals; Spleen; Yttrium Radioisotopes | 2011 |
Radioembolization of hepatic tumors: flow redistribution after the occlusion of intrahepatic arteries.
Topics: Aged; Aged, 80 and over; Angiography, Digital Subtraction; Breast Neoplasms; Carcinoma, Hepatocellular; Collateral Circulation; Colorectal Neoplasms; Embolization, Therapeutic; Female; Hepatic Artery; Humans; Liver Neoplasms; Male; Neoplasms, Unknown Primary; Neovascularization, Pathologic; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2011 |
18F-FDG PET/CT predicts survival after radioembolization of hepatic metastases from breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Cholangiocarcinoma; Embolization, Therapeutic; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Karnofsky Performance Status; Liver Neoplasms; Magnetic Resonance Imaging; Microspheres; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Survival Analysis; Tomography, X-Ray Computed; Young Adult; Yttrium Radioisotopes | 2012 |
Yttrium-90 -- current status, expected availability and applications of a high beta energy emitter.
Topics: Antibodies, Monoclonal, Humanized; Beta Particles; Biotin; Breast Neoplasms; Cation Exchange Resins; Equipment Design; Female; Humans; Organometallic Compounds; Radionuclide Generators; Radiopharmaceuticals; Yttrium Radioisotopes | 2012 |
Radioembolisation with (90)Y-labelled resin microspheres in the treatment of liver metastasis from breast cancer.
Topics: Breast Neoplasms; Chemoembolization, Therapeutic; Disease Progression; Female; Humans; Liver Function Tests; Liver Neoplasms; Microspheres; Middle Aged; Survival Rate; Treatment Outcome; Yttrium Radioisotopes | 2013 |
3D dosimetry in patients with early breast cancer undergoing Intraoperative Avidination for Radionuclide Therapy (IART) combined with external beam radiation therapy.
Topics: Avidin; Biotin; Breast Neoplasms; Female; Humans; Multimodal Imaging; Organometallic Compounds; Positron-Emission Tomography; Radiometry; Radiopharmaceuticals; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2012 |
Gastroduodenal ulceration after selective internal radiation therapy of liver tumor.
Topics: Brachytherapy; Breast Neoplasms; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Middle Aged; Radiation Injuries; Stomach Ulcer; Yttrium Radioisotopes | 2012 |
Labeling anti-HER2/neu monoclonal antibodies with 111In and 90Y using a bifunctional DTPA chelating agent.
Topics: Antibodies, Monoclonal; Breast Neoplasms; Female; Humans; Immunoconjugates; Immunoglobulin G; Indium Radioisotopes; Isothiocyanates; Isotope Labeling; Pentetic Acid; Receptor, ErbB-2; Stereoisomerism; Tumor Cells, Cultured; Yttrium Radioisotopes | 2003 |
Hypophysectomy combined with intrasellar irradiation with yttrium-90.
Topics: Breast; Breast Neoplasms; Humans; Hypophysectomy; Mastectomy; Neoplasms; Yttrium; Yttrium Radioisotopes | 1958 |
Screw-implantation of the pituitary with yttrium-90.
Topics: Bone Screws; Breast; Breast Neoplasms; Humans; Pituitary Gland; Yttrium; Yttrium Radioisotopes | 1958 |
Pernasal transsphenoidal yttrium implant of the hypophysis.
Topics: Breast Neoplasms; Humans; Male; Pituitary Gland; Prostatic Neoplasms; Prostheses and Implants; Yttrium; Yttrium Radioisotopes | 1958 |
Needle implantation of yttrium seeds for pituitary ablation in cases of secondary carcinoma.
Topics: Breast; Breast Neoplasms; Carcinoma; Humans; Needles; Pituitary Gland; Yttrium; Yttrium Radioisotopes | 1959 |
Transcranial yttrium90 hypophysectomy.
Topics: Breast; Breast Neoplasms; Humans; Hypophysectomy; Radioactivity; Yttrium; Yttrium Radioisotopes | 1959 |
Interstitial irradiation of the pituitary.
Topics: Brachytherapy; Breast Neoplasms; Gold Radioisotopes; Humans; Pituitary Diseases; Pituitary Gland; Yttrium; Yttrium Radioisotopes | 1960 |
[Implantation of intrapituitary radioactive material (Au-198 and Y-90) in metastatic cancers of the breast. Clinical and biological review apropos of 75 cases].
Topics: Breast; Breast Neoplasms; Gold Radioisotopes; Humans; Hypophysectomy; Neoplasms; Neoplasms, Second Primary; Yttrium; Yttrium Radioisotopes | 1961 |
Treatment of advanced breast cancer by yttrium-90 implantation of the pituitary.
Topics: Breast; Breast Neoplasms; Humans; Neoplasms; Pituitary Diseases; Yttrium; Yttrium Radioisotopes | 1959 |
[Implantation of radioactive yttrium (Y90) in the sella turcica in the treatment of breast and prostate carcinoma in the advanced stage (considerations on 21 cases)].
Topics: Breast; Breast Neoplasms; Humans; Hypophysectomy; Male; Neoplasms; Prostatic Neoplasms; Sella Turcica; Yttrium; Yttrium Radioisotopes | 1959 |
[The effect of pituitary destruction on choroid metastases following breast cancer].
Topics: Breast Neoplasms; Choroid; Choroid Neoplasms; Humans; Pituitary Gland; Yttrium; Yttrium Radioisotopes | 1961 |
Metastatic breast cancer in a 54-year-old woman: integrative treatment with yttrium-90 radioembolization.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carcinoembryonic Antigen; Embolization, Therapeutic; Female; Humans; Liver Neoplasms; Middle Aged; Neoplasm Metastasis; Yttrium Radioisotopes | 2004 |
A single treatment of yttrium-90-labeled CHX-A"-C6.5 diabody inhibits the growth of established human tumor xenografts in immunodeficient mice.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Immunoglobulin Variable Region; Immunotoxins; Isothiocyanates; Mice; Mice, Nude; Mice, SCID; Ovarian Neoplasms; Pentetic Acid; Radioimmunotherapy; Radionuclide Imaging; Receptor, ErbB-2; Tissue Distribution; Xenograft Model Antitumor Assays; Yttrium Radioisotopes | 2004 |
Efficacy of trastuzumab.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Mice; Radiography; Radioimmunotherapy; Receptor, ErbB-2; Trastuzumab; Xenograft Model Antitumor Assays; Yttrium Radioisotopes | 2005 |
Planning time for peripheral blood stem cell infusion after high-dose targeted radionuclide therapy using dosimetry.
Topics: Antibodies, Monoclonal; Antigens, Tumor-Associated, Carbohydrate; Breast Neoplasms; Cells, Cultured; Female; Humans; Indium Radioisotopes; Peripheral Blood Stem Cell Transplantation; Radioimmunotherapy; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Time Factors; Yttrium Radioisotopes | 2005 |
Enhanced efficacy of 90Y-radiolabeled anti-Lewis Y humanized monoclonal antibody hu3S193 and paclitaxel combined-modality radioimmunotherapy in a breast cancer model.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Combined Modality Therapy; Female; Humans; Lewis Blood Group Antigens; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Paclitaxel; Radioimmunotherapy; Radiopharmaceuticals; Tissue Distribution; Transplantation, Heterologous; Yttrium Radioisotopes | 2006 |
[Liver cirrhosis as sequela of selective hepatic radio-embolization with Yttrium (Y-90) microspheres].
Topics: Angiography; Breast Neoplasms; Embolization, Therapeutic; Female; Hepatic Artery; Humans; Injections, Intra-Arterial; Liver Cirrhosis; Liver Neoplasms; Microspheres; Middle Aged; Palliative Care; Positron-Emission Tomography; Radiotherapy; Radiotherapy Dosage; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes | 2006 |
Comparison of normal tissue pharmacokinetics with 111In/90Y monoclonal antibody m170 for breast and prostate cancer.
Topics: Antibodies, Monoclonal; Breast Neoplasms; Female; Humans; Indium Radioisotopes; Male; Metabolic Clearance Rate; Organ Specificity; Prostatic Neoplasms; Radiopharmaceuticals; Tissue Distribution; Yttrium Radioisotopes | 2006 |
IART: intraoperative avidination for radionuclide treatment. A new way of partial breast irradiation.
Topics: Adult; Avidin; Biotin; Brachytherapy; Breast Neoplasms; Combined Modality Therapy; Female; Humans; Injections, Intralesional; Injections, Intravenous; Intraoperative Period; Mastectomy, Segmental; Middle Aged; Radiometry; Radionuclide Imaging; Radiotherapy Dosage; Radiotherapy, Adjuvant; Yttrium Radioisotopes | 2007 |
Use of yttrium-90 microspheres in the treatment of unresectable hepatic metastases from breast cancer.
Topics: Adult; Aged; Brachytherapy; Breast Neoplasms; Female; Follow-Up Studies; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Microspheres; Middle Aged; Survival Analysis; Tomography, X-Ray Computed; Yttrium Radioisotopes | 2007 |
The toxicity of liver directed yttrium-90 microspheres in primary and metastatic liver tumors.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Female; Hepatic Artery; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Pancreatic Neoplasms; Retrospective Studies; Survival Rate; Yttrium Radioisotopes | 2008 |
Radioembolization in patients with hepatic metastases from breast cancer.
Topics: Adult; Aged; Brachytherapy; Breast Neoplasms; Chi-Square Distribution; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Microspheres; Middle Aged; Prospective Studies; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Yttrium Radioisotopes | 2008 |
[Treatment of pains from bone metastases with 90Y (author's transl)].
Topics: Bone Neoplasms; Breast Neoplasms; Female; Half-Life; Humans; Lung Neoplasms; Male; Melanoma; Pain, Intractable; Palliative Care; Prostatic Neoplasms; Radiotherapy Dosage; Stomach Neoplasms; Yttrium Radioisotopes | 1981 |
[Interstitial radiotherapy].
Topics: Brachytherapy; Breast Neoplasms; Cobalt Radioisotopes; Gold Radioisotopes; Head and Neck Neoplasms; Humans; Iodine Radioisotopes; Iridium; Male; Mouth Neoplasms; Pituitary Neoplasms; Prostatic Neoplasms; Radioisotope Teletherapy; Radioisotopes; Tantalum; Urinary Bladder Neoplasms; Yttrium Radioisotopes | 1983 |
Prelabeling of chimeric monoclonal antibody L6 with 90yttrium- and 111indium-1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid (DOTA) chelates for radioimmunodiagnosis and therapy.
Topics: Animals; Antibodies, Bispecific; Antibodies, Monoclonal; Antibodies, Neoplasm; Breast Neoplasms; Drug Delivery Systems; Female; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Isotope Labeling; Mice; Mice, Nude; Radioimmunotherapy; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes | 1995 |
Yttrium-90 chimeric L6 therapy of human breast cancer in nude mice and apoptosis-related messenger RNA expression.
Topics: Animals; Antibodies, Monoclonal; Apoptosis; Base Sequence; Breast Neoplasms; Female; Gene Expression; Humans; Mice; Mice, Nude; Molecular Sequence Data; Neoplasm Transplantation; Radioimmunotherapy; RNA, Messenger; Transplantation, Heterologous; Yttrium Radioisotopes | 1995 |
Measurement of pharmacokinetics of yttrium-86 radiopharmaceuticals with PET and radiation dose calculation of analogous yttrium-90 radiotherapeutics.
Topics: Adult; Bone Neoplasms; Breast Neoplasms; Citrates; Female; Humans; Organometallic Compounds; Radiotherapy Dosage; Tomography, Emission-Computed; Yttrium Radioisotopes | 1993 |
Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells.
Topics: Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antigens, Neoplasm; Breast Neoplasms; Carcinoma; Colorectal Neoplasms; Drug Carriers; Female; HL-60 Cells; Humans; Immunoconjugates; Indium Radioisotopes; Iodine Radioisotopes; Liposomes; Radioimmunotherapy; Sialic Acid Binding Ig-like Lectin 3; Yttrium Radioisotopes | 1996 |
Synergy of Taxol and radioimmunotherapy with yttrium-90-labeled chimeric L6 antibody: efficacy and toxicity in breast cancer xenografts.
Topics: Animals; Antibodies; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Combined Modality Therapy; Female; Humans; Interleukin-6; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms, Experimental; Paclitaxel; Radioimmunotherapy; Transplantation, Heterologous; Yttrium Radioisotopes | 1997 |
Yttrium-90-DOTA-peptide-chimeric L6 radioimmunoconjugate: efficacy and toxicity in mice bearing p53 mutant human breast cancer xenografts.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Apoptosis; Breast Neoplasms; Dose-Response Relationship, Radiation; Female; Heterocyclic Compounds; Humans; Lethal Dose 50; Mice; Mice, Nude; Neoplasm Transplantation; Oligopeptides; Radioimmunotherapy; Transplantation, Heterologous; Tumor Suppressor Protein p53; Yttrium; Yttrium Radioisotopes | 1998 |
Initial clinical evaluation of radiolabeled MX-DTPA humanized BrE-3 antibody in patients with advanced breast cancer.
Topics: Adult; Antibodies, Monoclonal; Breast Neoplasms; Female; Humans; Indium Radioisotopes; Middle Aged; Pentetic Acid; Radioimmunotherapy; Radiotherapy Dosage; Tomography, Emission-Computed, Single-Photon; Yttrium Radioisotopes | 1998 |
DOTA-lanreotide: a novel somatostatin analog for tumor diagnosis and therapy.
Topics: Adenocarcinoma; Animals; Breast Neoplasms; Carcinoid Tumor; Cell Membrane; Colonic Neoplasms; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Liver Neoplasms; Lymphoma, Non-Hodgkin; Male; Neoplasms; Pancreatic Neoplasms; Peptides, Cyclic; Prostatic Neoplasms; Rats; Rats, Sprague-Dawley; Thyroid Neoplasms; Tissue Distribution; Tumor Cells, Cultured; Yttrium Radioisotopes | 1999 |
Dosimetry-based therapy in metastatic breast cancer patients using 90Y monoclonal antibody 170H.82 with autologous stem cell support and cyclosporin A.
Topics: Adult; Animals; Antibodies, Monoclonal; Breast Neoplasms; Cyclosporine; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Mice; Middle Aged; Neoplasm Metastasis; Radioimmunotherapy; Radiotherapy Dosage; Transplantation, Autologous; Yttrium Radioisotopes | 1999 |
In vivo biodistribution of a humanized anti-Lewis Y monoclonal antibody (hu3S193) in MCF-7 xenografted BALB/c nude mice.
Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Autoradiography; Breast Neoplasms; Drug Stability; Female; Half-Life; Humans; Immunohistochemistry; Indium Radioisotopes; Iodine Radioisotopes; Isotope Labeling; Lewis Blood Group Antigens; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Radionuclide Imaging; Tissue Distribution; Transplantation, Heterologous; Tumor Cells, Cultured; Yttrium Radioisotopes | 2000 |
Radiosensitization of tumor-targeted radioimmunotherapy with prolonged topotecan infusion in human breast cancer xenografts.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Agents; Apoptosis; Bone Marrow; Breast Neoplasms; Cell Division; Combined Modality Therapy; Drug Synergism; Enzyme Inhibitors; Female; Humans; Immunoglobulin G; Immunotoxins; Mice; Mice, Nude; Pentetic Acid; Radiation Tolerance; Radioimmunotherapy; Topotecan; Tumor Cells, Cultured; Xenograft Model Antitumor Assays; Yttrium Radioisotopes | 2001 |
[The efficacy of radiohypophysectomy with yttrium 90 in metastatic breast cancer (author's transl)].
Topics: Austria; Breast Neoplasms; Female; Hospitals, University; Humans; Neoplasm Metastasis; Palliative Care; Pituitary Irradiation; Yttrium Radioisotopes | 1979 |
Pituitary function and clinical response in breast cancer patients after yttrium implantation.
Topics: Breast Neoplasms; Female; Follicle Stimulating Hormone; Growth Hormone; Humans; Luteinizing Hormone; Pituitary Function Tests; Pituitary Gland; Pituitary Irradiation; Thyrotropin; Yttrium Radioisotopes | 1979 |
The sublabial transseptal transsphenoidal approach to the hypophysis.
Topics: Breast Neoplasms; Cryosurgery; Diabetic Retinopathy; Gold Radioisotopes; Headache; Humans; Hypophysectomy; Male; Pituitary Gland; Pituitary Irradiation; Pituitary Neoplasms; Prostatic Neoplasms; Sella Turcica; Skull; Sphenoid Sinus; Surgical Instruments; Ultrasonics; Yttrium Radioisotopes | 1978 |
Today and tomorrow: radiochemistry for radioimmunotherapy of breast cancer.
Topics: Animals; Antibodies, Monoclonal; Breast Neoplasms; Chelating Agents; Copper Radioisotopes; Female; Humans; Immunotherapy; Immunotoxins; Lymphoma; Mice; Yttrium Radioisotopes | 1990 |
Beneficial response to pituitary ablation following aminoglutethimide.
Topics: Adult; Aged; Aminoglutethimide; Breast Neoplasms; Female; Humans; Hypophysectomy; Middle Aged; Tamoxifen; Yttrium Radioisotopes | 1986 |